Impact of baseline hepatitis B virus viral load on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy

Figure 2 Graph showing the effect of different levels of hepatitis B virus-DNA on long-term survival of patients and further subgroup analysis according to antiviral treatment. A: Kaplan Meier plot of progression-free survival in the hepatitis B virus (HBV)-DNA ≤ 2000 and HBV-DNA > 2000 groups; B: Kaplan Meier plot of overall survival (OS) in the HBV-DNA ≤ 2000 and HBV-DNA > 2000 groups; C: Kaplan Meier plot of Analysis of progression-free survival subgroup by antiviral therapy; D: Kaplan Meier plot of Analysis of OS subgroup by antiviral therapy. HBV: Hepatitis B virus.